At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Transcranial alternating current stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Enhancing Cognitive Control in Mild Cognitive Impairment Via Non-invasive Brain Stimulation
In Brief
A clinical study evaluating Transcranial alternating current stimulation for Mild Cognitive Impairment. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The overall goal of this project is to improve cognitive control abilities in adults with mild cognitive impairment (MCI) through a form of non-invasive brain stimulation, transcranial alternating current stimulation (tACS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMild Cognitive Impairment
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA)
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedNov 2020
Enrollment StartJan 2021
Primary CompletionDec 2021
Study CompletionMay 2022
TodayJul 2026
First PostedNov 30, 2020
Enrollment StartJan 11, 2021
Primary CompletionDec 31, 2021
Study CompletionMay 31, 2022
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 5.6 years ago
Interventions
Transcranial alternating current stimulationdevice
Transcranial alternating current stimulation (tACS) will be applied across the prefrontal cortex near electrodes coordinates AF3/AF4